IL17A and hepatocellular carcinoma: Decreased levels of cytokines mediating immunosuppression (i.e., IL-6), inhibition of autophagy, and promotion of cell migration (i.e., IL-17) together with the development of enriched granulocyte-macrophage colony-forming cells (i.e., SCF) may be interpreted as the experimental data showing immunostimulatory effects, which ameliorate HCC progression.